You are here

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study

Authors

  • Xavier Mariette Université Paris-Sud, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris-Sud, INSERM U1012, Le Kremlin Bicêtre, France PubMed articlesGoogle scholar articles
  • Raphaèle Seror Université Paris-Sud, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris-Sud, INSERM U1012, Le Kremlin Bicêtre, France PubMed articlesGoogle scholar articles
  • Luca Quartuccio Department of Medical and Biological Sciences, Clinic of Rheumatology, Udine University, Udine, Italy PubMed articlesGoogle scholar articles
  • Gabriel Baron Faculty of Medicine, AP-HP, Hôtel Dieu Hospital, Centre of Clinical Epidemiology, INSERM, U738, University of Paris Descartes, Paris, France PubMed articlesGoogle scholar articles
  • Sara Salvin Department of Medical and Biological Sciences, Clinic of Rheumatology, Udine University, Udine, Italy PubMed articlesGoogle scholar articles
  • Martina Fabris Department of Medical and Biological Sciences, Clinic of Rheumatology, Udine University, Udine, Italy Institute of Clinical Pathology, University Hospital of Udine, Udine, Italy PubMed articlesGoogle scholar articles
  • Frederic Desmoulins Université Paris-Sud, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris-Sud, INSERM U1012, Le Kremlin Bicêtre, France PubMed articlesGoogle scholar articles
  • Gaétane Nocturne Université Paris-Sud, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris-Sud, INSERM U1012, Le Kremlin Bicêtre, France PubMed articlesGoogle scholar articles
  • Philippe Ravaud Faculty of Medicine, AP-HP, Hôtel Dieu Hospital, Centre of Clinical Epidemiology, INSERM, U738, University of Paris Descartes, Paris, France PubMed articlesGoogle scholar articles
  • Salvatore De Vita Department of Medical and Biological Sciences, Clinic of Rheumatology, Udine University, Udine, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Xavier Mariette, Service de Rhumatologie, Hôpital Bicêtre, 78 rue du Général Leclerc, Le Kremlin Bicêtre 94275, France; xavier.mariette{at}bct.aphp.fr
View Full Text

Citation

Mariette X, Seror R, Quartuccio L, et al
Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study
Annals of the Rheumatic Diseases 2015;74:526-531.

Publication history

  • Received May 22, 2013
  • Revised September 27, 2013
  • Accepted November 24, 2013
  • First published December 17, 2013.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions